A case of bullous pemphigoid nduced by vildagliptin

Keseroglu H. O., Tas-Aygar G., Gonul M., GÖKÖZ Ö., Ersoy-Evans S.

CUTANEOUS AND OCULAR TOXICOLOGY, cilt.36, sa.2, ss.201-202, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 36 Sayı: 2
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1080/15569527.2016.1211670
  • Dergi Adı: CUTANEOUS AND OCULAR TOXICOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.201-202
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Bullous pemfigoid (BP), an autoimmune disorder, can also be induced by some medications. Vildagliptin is a new drug used to treat diabetes mellitus (DM). Recently, a few cases of vildagliptin-induced BP have been described in the literature. We report a patient with BP in which vildagliptin was thought to be as a possible causative agent. The awareness of BP development risk during gliptin therapy can prevent unnecessary usage of systemic drugs with serious side effects.